SCHINDELLEGI, SCHWYZ, SWITZERLAND, January 27, 2026 /EINPresswire.com/ — AsedaSciences ®, a leader in the integration of New Approach Methods (NAMs) and digital ...
The US Food and Drug Administration (FDA) has detailed its thinking on how and when it is acceptable to conduct first-in-human (FIH) trials of drugs with mutagenic potential. The agency takes a ...
Toxicity-testing strategies designed to generate information on potential hazards or risks posed by environmental agents have evolved in response to legislative mandates, scientific developments, and ...
WHILE admitting that mammals would be preferable to diptera for testing newly introduced drugs for possible genetic (that is, mutagenic) effects, Prof. Lüning 1 argues that tests with mice would be ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results